ARTICLE | Clinical News
Polyphor reports Ph II murepavadin data
May 5, 2017 1:40 AM UTC
Polyphor Ltd. (Allschwil, Switzerland) reported that thrice-daily 2.5 mg/kg IV murepavadin (POL7080, RG7929) for 10-14 days plus standard of care (SOC) led to a clinical cure rate at the test-of-cure ...
BCIQ Company Profiles
BCIQ Target Profiles